| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021792 |
| Receipt No. | R000025134 |
| Official scientific title of the study | Examination of the relationship between Alzheimer's disease and arteriosclerosis |
| Date of disclosure of the study information | 2016/04/07 |
| Last modified on | 2018/04/09 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Examination of the relationship between Alzheimer's disease and arteriosclerosis | |
| Title of the study (Brief title) | Examination of the relationship between Alzheimer's disease and arteriosclerosis | |
| Region |
|
|
| Condition | ||||
| Condition | Alzheimer's disease, Mild cognitive impairment, Elderly persons without cognitive impairment | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | Alzheimer's disease often have arteriosclerosis. The aim of this study is to investigate the relationship between pathophysiology of Alzheimer's disease and arteriosclerosis. |
| Basic objectives2 | Others |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Arteriosclerosis-related tests (Flow Mediated Dilation:FMD, Arterial Pressure volume Index:API, Arterial Velocity pulse Index:AVI), cerebrospinal fluid tests, Touch Panel-type Dementia Assessment Scale(TDAS) |
| Key secondary outcomes | Blood tests (total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride, glucose) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Arteriosclerosis-related tests, cerebrospinal fluid tests, examination of cognitive function, blood tests | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Subjects who are 20-89 years old at the time of registration
2) Alzheimer's disease patients who fulfill of the DSM-5 and NINCDS-ADRDA criteria, or mild cognitive impairment patients who fulfill of the Petersen criteria, or subjects who don't have cognitive impairment. 3) In the Alzheimer's disease and mild cognitive impairment patients, the consent from proxies is necessary. 4) Patients who performed the cerebrospinal fluid and blood tests (total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride, glucose) within three months. |
|||
| Key exclusion criteria | 1) Patients who are judged difficulty depiction of brachial artery or pressure of forearm.
2) Patients who have more than 200 mmHg in resting systolic pressure. 3) Patients who are assessed by the principal investigator due to other reasons. |
|||
| Target sample size | 90 | |||
| Research contact person | |
| Name of lead principal investigator | Katsuya Urakami |
| Organization | School of Health Science, Faculty of Medicine, Tottori University |
| Division name | Department of Biological Regulation |
| Address | 86 Nishicho, Yonago, Tottori, Japan |
| TEL | 0859-38-6354 |
| kurakami@med.tottori-u.ac.jp | |
| Public contact | |
| Name of contact person | Minoru Kouzuki |
| Organization | School of Health Science, Faculty of Medicine, Tottori University |
| Division name | Department of Biological Regulation |
| Address | 86 Nishicho, Yonago, Tottori, Japan |
| TEL | 0859-38-6358 |
| Homepage URL | |
| kouzuki@med.tottori-u.ac.jp | |
| Sponsor | |
| Institute | Department of Biological Regulation, School of Health Science, Faculty of Medicine, Tottori University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025134 |